Fidelity Investments’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $111M | Buy |
5,439,118
+59,027
| +1% | +$1.2M | 0.01% | 1075 |
|
2025
Q1 | $97.6M | Buy |
5,380,091
+522,423
| +11% | +$9.48M | 0.01% | 1109 |
|
2024
Q4 | $123M | Sell |
4,857,668
-1,166,748
| -19% | -$29.5M | 0.01% | 1034 |
|
2024
Q3 | $205M | Sell |
6,024,416
-1,804,748
| -23% | -$61.3M | 0.01% | 818 |
|
2024
Q2 | $290M | Sell |
7,829,164
-1,896,877
| -20% | -$70.2M | 0.02% | 647 |
|
2024
Q1 | $408M | Buy |
9,726,041
+2,675,632
| +38% | +$112M | 0.03% | 518 |
|
2023
Q4 | $280M | Sell |
7,050,409
-38,711
| -0.5% | -$1.54M | 0.02% | 620 |
|
2023
Q3 | $195M | Buy |
7,089,120
+1,250
| +0% | +$34.4K | 0.02% | 711 |
|
2023
Q2 | $240M | Buy |
7,087,870
+6,792
| +0.1% | +$230K | 0.02% | 654 |
|
2023
Q1 | $255M | Buy |
7,081,078
+16,104
| +0.2% | +$579K | 0.02% | 616 |
|
2022
Q4 | $315M | Buy |
7,064,974
+49,131
| +0.7% | +$2.19M | 0.03% | 541 |
|
2022
Q3 | $197M | Buy |
7,015,843
+2,699
| +0% | +$75.9K | 0.02% | 664 |
|
2022
Q2 | $189M | Buy |
7,013,144
+2,891
| +0% | +$77.9K | 0.02% | 708 |
|
2022
Q1 | $239M | Buy |
7,010,253
+10,673
| +0.2% | +$364K | 0.02% | 693 |
|
2021
Q4 | $270M | Buy |
6,999,580
+1,384,247
| +25% | +$53.5M | 0.02% | 677 |
|
2021
Q3 | $303M | Buy |
5,615,333
+5,249,038
| +1,433% | +$283M | 0.02% | 632 |
|
2021
Q2 | $12.2M | Buy |
366,295
+28,395
| +8% | +$949K | ﹤0.01% | 2029 |
|
2021
Q1 | $6.96M | Buy |
337,900
+337,899
| +33,789,900% | +$6.96M | ﹤0.01% | 2160 |
|
2020
Q4 | $0 | Sell |
1
-72
| -99% | – | ﹤0.01% | 3860 |
|
2020
Q3 | $1K | Buy |
+73
| New | +$1K | ﹤0.01% | 3536 |
|
2020
Q1 | – | Sell |
-50
| Closed | – | – | 3673 |
|
2019
Q4 | $0 | Buy |
50
+30
| +150% | – | ﹤0.01% | 3821 |
|
2019
Q3 | $0 | Buy |
+20
| New | – | ﹤0.01% | 3811 |
|
2019
Q1 | – | Sell |
-280
| Closed | -$1K | – | 3657 |
|
2018
Q4 | $1K | Hold |
280
| – | – | ﹤0.01% | 3379 |
|
2018
Q3 | $2K | Buy |
+280
| New | +$2K | ﹤0.01% | 3378 |
|
2018
Q2 | – | Sell |
-397,901
| Closed | -$13.9M | – | 2647 |
|
2018
Q1 | $13.9M | Sell |
397,901
-110,282
| -22% | -$3.85M | ﹤0.01% | 1850 |
|
2017
Q4 | $21.6M | Sell |
508,183
-88,140
| -15% | -$3.75M | ﹤0.01% | 1687 |
|
2017
Q3 | $25.6M | Sell |
596,323
-53,974
| -8% | -$2.32M | ﹤0.01% | 1603 |
|
2017
Q2 | $24.1M | Sell |
650,297
-289,944
| -31% | -$10.7M | ﹤0.01% | 1600 |
|
2017
Q1 | $50.9M | Sell |
940,241
-348,233
| -27% | -$18.9M | 0.01% | 1286 |
|
2016
Q4 | $68.4M | Buy |
1,288,474
+370,373
| +40% | +$19.7M | 0.01% | 1165 |
|
2016
Q3 | $55.6M | Sell |
918,101
-7,060
| -0.8% | -$428K | 0.01% | 1251 |
|
2016
Q2 | $60.9M | Sell |
925,161
-52,560
| -5% | -$3.46M | 0.01% | 1185 |
|
2016
Q1 | $55.4M | Sell |
977,721
-8,736
| -0.9% | -$495K | 0.01% | 1208 |
|
2015
Q4 | $232M | Buy |
986,457
+21,283
| +2% | +$5.01M | 0.03% | 598 |
|
2015
Q3 | $153M | Sell |
965,174
-19,634
| -2% | -$3.1M | 0.02% | 770 |
|
2015
Q2 | $373M | Buy |
984,808
+16,380
| +2% | +$6.2M | 0.05% | 426 |
|
2015
Q1 | $405M | Buy |
968,428
+72,537
| +8% | +$30.3M | 0.05% | 411 |
|
2014
Q4 | $245M | Buy |
895,891
+91,853
| +11% | +$25.1M | 0.03% | 589 |
|
2014
Q3 | $156M | Buy |
804,038
+413
| +0.1% | +$80.3K | 0.02% | 760 |
|
2014
Q2 | $197M | Buy |
803,625
+7,925
| +1% | +$1.94M | 0.03% | 678 |
|
2014
Q1 | $211M | Sell |
795,700
-14,788
| -2% | -$3.92M | 0.03% | 630 |
|
2013
Q4 | $294M | Buy |
810,488
+14,492
| +2% | +$5.26M | 0.04% | 461 |
|
2013
Q3 | $423M | Buy |
795,996
+484,781
| +156% | +$258M | 0.06% | 348 |
|
2013
Q2 | $72.9M | Buy |
+311,215
| New | +$72.9M | 0.01% | 1063 |
|